Enigmatic sex disparities in cancer incidence

European Journal of Epidemiology

Volumn 27, Issue 3, 2012, Pages 187-196

  Edgren, Gustaf ^a,b   Liang, Liming ^b   Adami, Hans Olov ^a,b   Chang, Ellen T ^c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Environmental risk factors; Gender; Gender Inequality; Genetic risk factors; Occupational risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; GROSS NATIONAL PRODUCT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; WORLD HEALTH;

EID: 84860315471     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9647-5     Document Type: Article

References (53)

1. Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. 2nd ed. New York: Oxford University Press; 2008.
2. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174-82.
3. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629-37.
4. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995; 333(1):32-41.
5. Czene K, Adami HO, Chang ET. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2496-9. (Pubitemid 351196387)
6. Schwartz EE, Upton AC. Factors influencing the incidence of leukemia: special consideration of the role of ionizing radiation. Blood. 1958;13(9):845-64.
7. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):421-9. (Pubitemid 35370755)
8. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003;12(2):144-50. (Pubitemid 36194004)
9. Gitschier J, Wood WI, Goralka TM, et al. Characterization of the human factor VIII gene. Nature. 1984;312(5992):326-30. (Pubitemid 15209308)
10. Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(8):686-91. (Pubitemid 350291635)
11. Curado MP, Edwards B, Shin HR, et al., editors. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007.
12. World Development Indicators [database on the Internet]. The World Bank. 2009. Available from: http://data.worldbank.org/.
13. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45(Suppl 2):S3-9. (Pubitemid 39488165)
14. MacKay J, Eriksen M. The tobacco atlas. Geneva: World Health Organization; 2002.
15. IARC monographs on the evaluation of carcinogenic risks to humans: tobacco smoke and involuntary smoking. Lyon: International Agency for Research on Cancer; 2002.
16. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A metaanalysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700-5. (Pubitemid 34081516)
17. IARC monographs on the evaluation of carcinogenic risks to humans: alcohol drinking. Lyon: International Agency for Research on Cancer; 1988.
18. Driscoll T, Steenland K, Prüss-Üstun A, Imel Nelson D, Leigh J. Occupational carcinogens: assessing the environmental burden of disease at national and local levels. Prüss-Üstün A, Campbell- Lendrum D, Corvalán C, Woodward A, editors. Geneva: World Health Organization; 2004.
19. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33(7): 1075-107. (Pubitemid 27310783)
20. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777-80.
21. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985;39(Suppl 1): 5-41.
22. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst. 1988;80(10):772-4.
23. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301-16.
24. IARC monographs on the evaluation of carcinogenic risks to humans: combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. Lyon: International Agency for Research on Cancer; 2005.
25. Liu J, Morgan M, Hutchison K, Calhoun VD. A study of the influence of sex on genome wide methylation. PLoS One. 2010;5(4): e10028.
26. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008;299(24):2877-83. (Pubitemid 351930887)
27. Kaminsky ZA, Tang T, Wang SC, et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet. 2009;41(2): 240-5.
28. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8): e1000602.
29. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102(30):10604- 9. (Pubitemid 41061601)
30. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11): 1148-59.
31. Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl 12):1-39. (Pubitemid 46732571)
32. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-9.
33. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med. 2003;349(14):1324-32. (Pubitemid 37186210)
34. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-20. (Pubitemid 30365531)
35. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976;17(1):1-7.
36. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2(8256):1129-33.
37. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2(8670):1004-6. (Pubitemid 19257915)
38. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev. 2008;7(8):626-30.
39. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737-44.
40. Inman RD. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthr Rheum. 1978;21(7):849-52. (Pubitemid 9126674)
41. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst. 1994;86(6):455-60. (Pubitemid 24081879)
42. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med. 1988;319(16):1047-52.
43. Hercberg S, Estaquio C, Czernichow S, et al. Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr. 2005;135(11): 2664-8. (Pubitemid 43156611)
44. Edgren G, Nyren O, Melbye M. Cancer as a ferrotoxic disease: are we getting hard stainless evidence? J Natl Cancer Inst. 2008;100(14):976-7. (Pubitemid 352019803)
45. Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008;100(8):572-9.
46. Beard JL, Dawson H, Pinero DJ. Iron metabolism: a comprehensive review. Nutr Rev. 1996;54(10):295-317. (Pubitemid 27129673)
47. Stevens RG. Iron and the risk of cancer. Med Oncol Tumor Pharmacother. 1990;7(2-3):177-81. (Pubitemid 20267987)
48. Zacharski LR, Chow BK, Howes PS, et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA. 2007;297(6): 603-10.
49. Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008; 100(14):996-1002. (Pubitemid 352019800)
50. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350-8. (Pubitemid 27467769)
51. Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007;8(4):311-6. (Pubitemid 46464521)
52. Fraumeni JF Jr. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res. 1975;35(11 Pt. 2): 3437-46.
53. Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20(6):1075-83. (Pubitemid 44774809)